论文部分内容阅读
布鲁斯·L·莱文(左),宾夕法尼亚大学佩雷尔曼医学院副教授,研究方向:癌症基因疗法;卡尔·H·朱恩(右),宾夕法尼亚大学佩雷尔曼医学院教授,研究方向:免疫疗法●布鲁斯·L·莱文(Bruce L.Levine)和卡尔·H·朱恩(Carl H.June)探索如何设计研制免疫细胞,以尽可能地根治癌症。神话中的吐火兽(与嵌合体为同一词),起源于古利西亚,集狮、山羊和毒蛇一体。两千年之后,向南几百公里之外,以色列魏兹曼科学研究所的科学家们描述了一种免疫细胞中的嵌合受体:T细胞。这种嵌合体由免疫抗体和T细胞受体组成,可以用于
Bruce L. Levine (left), Associate Professor, Perelman College of Medicine, University of Pennsylvania Research Interests: Cancer Gene Therapy; Carl H. Juen (right), Professor, Perelman College of Medicine, University of Pennsylvania Research Interests: Immunotherapy ● Bruce L. Levine and Carl H. June explore how to design and develop immune cells to cure cancer as much as possible. Mythical spit fire beast (with chimera for the same word), originated in ancient Lycian, set lion, goat and poisonous snake one. Two thousand years later, hundreds of kilometers south, scientists at the Weizmann Institute of Science in Israel described a chimeric receptor in immune cells: T cells. This chimera consists of immune antibodies and T cell receptors and can be used